U-Chart Analysis:Noile-Immune Biotech Inc.:4893

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Noile-Immune Biotech Inc. 4893 Medicals 東証グロース December 1, 2000 2023.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Noile-Immune Biotech Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Noile-Immune Biotech Inc. Balance Sheet 2023年12月期 Noile-Immune Biotech Inc. Balance Sheet 2022年12月期 Noile-Immune Biotech Inc. Balance Sheet 2021年12月期 Noile-Immune Biotech Inc. Balance Sheet 2020年12月期 Noile-Immune Biotech Inc. Balance Sheet 年0月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents 5,556 4,521 4,141 2,548 -
Other Current AssetsHelp 161 63 85 111 -
Tangible Fixed AssetsHelp - 0 0 0 -
Intangible Fixed AssetHelp 0 0 0 0 -
Investments and OthersHelp 62 57 46 15 -
Total AssetsHelp 5,779 4,641 4,271 2,674 -
Total Current LiabilitiesHelp 91 340 86 76 -
Total Long-term LiabilitiesHelp 0 0 0 0 -
Shareholder's EquityHelp 5,687 4,301 4,185 2,598 -
Total LiabilitiesHelp 5,779 4,641 4,271 2,674 -

Noile-Immune Biotech Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Noile-Immune Biotech Inc. Profit and Loss Account 2023年12月期 Noile-Immune Biotech Inc. Profit and Loss Account 2022年12月期 Noile-Immune Biotech Inc. Profit and Loss Account 2021年12月期 Noile-Immune Biotech Inc. Profit and Loss Account 2020年12月期 Noile-Immune Biotech Inc. Profit and Loss Account 年0月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales 317 626 101 97 -
Total Sales 317 626 101 97 -
Cost of SalesHelp 2 7 23 3 -
Other Costs and RevenueHelp 1,445 1,005 873 731 -
Total CostsHelp 1,447 1,012 896 734 -
Net RevenueHelp 315 619 78 94 -
Earnings Before TaxHelp -1,128 -384 -793 -631 -
Net IncomeHelp -1,130 -387 -795 -637 -
Net Income -1,130 -387 -795 -637 -

Noile-Immune Biotech Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Noile-Immune Biotech Inc. Cash Flow Statement 2023年12月期 Noile-Immune Biotech Inc. Cash Flow Statement 2022年12月期 Noile-Immune Biotech Inc. Cash Flow Statement 2021年12月期 Noile-Immune Biotech Inc. Cash Flow Statement 2020年12月期 Noile-Immune Biotech Inc. Cash Flow Statement 年0月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help -873 -107 -777 -301 -
Investing Cash Flow(ICF)Help - -5 -4 -4 -
Financing Cash FlowHelp 1,913 488 2,374 996 -
Exchange Difference of Cash and Cash EquivalentsHelp - 5 0 4 -
Net Increase and Decrease in Cash and Cash Equivalentsn 1,035 380 1,592 696 -

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Noile-Immune Biotech Inc.

Company where related level is highHelp

HEALIOS K.K.
OncoTherapy Science,Inc.
SAWAI GROUP HOLDINGS Co., Ltd.
Oncolys BioPharma Inc.
BIOFERMIN PHARMACEUTICAL CO.,LTD.
EIKEN CHEMICAL CO.,LTD.
Eisai Co.,Ltd.
NIPPON CHEMIPHAR CO.,LTD.
STELLA PHARMA CORPORATION
MIKASA SEIYAKU CO.,LTD.